Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
YT-1920 by Bristar Immunotech Biotechnology for B-Cell Leukemia: Likelihood of Approval
YT-1920 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for B-Cell Leukemia. According to GlobalData,...
YT-1920 by Bristar Immunotech Biotechnology for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
YT-1920 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell...
YT-1920 by China Immunotech for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
YT-1920 is under clinical development by China Immunotech and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute...
YT-1920 by China Immunotech for B-Cell Leukemia: Likelihood of Approval
YT-1920 is under clinical development by China Immunotech and currently in Phase I for B-Cell Leukemia. According to GlobalData, Phase...